Assignee
ROSE PHARMA INC
US·1 granted patent·2 pending applications·0 citations·filing 2021–2025
Top patents by PatentIndex Score
3 records- 0165US2024293515A1Stable liquid formulations of glucagon-like peptide 1 or analogues thereofROSE PHARMA INC·Filed 2024·Application pending·0 cites
- 0257US11980655B2Methods of treatment with stable liquid formulations of glucagon-like peptide 1 or analogues thereofROSE PHARMA INC·Filed 2021·Granted May 14, 2024·0 cites·18 claims
- 0342US2025352622A1Glp-1 formulations and their usesROSE PHARMA INC·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →